CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-13 | Bencich John CFO & COO | Option exercise | +1,443 | 1,578 | ||
| 2018-08-13 | Bencich John CFO & COO | Shares withheld for taxes | −458 | $2.78 | $1K | 1,120 |
| 2018-08-13 | Bencich John CFO & COO | Option exercise · Restricted Stock Unit (RSU) | −1,370 | 4,110 | ||
| 2018-08-13 | Bencich John CFO & COO | Option exercise · Restricted Stock Unit (RSU) | −45 | 0 | ||
| 2018-08-13 | Bencich John CFO & COO | Option exercise · Restricted Stock Unit (RSU) | −28 | 28 | ||
| 2018-07-26 | Stewart Richard Alistair Chairman & CEO | Grant or award · Stock Option (right to buy) | +52,000 | 52,000 | ||
| 2018-07-26 | JACOBS CINDY EVP, CMO | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-07-26 | Clarke Anthony President & CSO | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-07-26 | Bencich John CFO & COO | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-10-10 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −3,125 | 3,125 | ||
| 2017-10-10 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −4,687 | 9,375 | ||
| 2017-09-08 | Bencich John CFO | Option exercise | +454 | 1,507 | ||
| 2017-09-08 | Bencich John CFO | Shares withheld for taxes | −149 | $3.09 | $460 | 1,358 |
| 2017-09-08 | Bencich John CFO | Option exercise · Restricted Stock Unit (RSU) | −454 | 455 | ||
| 2017-09-08 | Cormack Scott Daniel Director | Shares withheld for taxes | −1,491 | $3.09 | $5K | 14,810 |
| 2017-08-01 | MOYES JAY M Director | Grant or award · Stock Option (right to buy) | +16,400 | 16,400 | ||
| 2017-08-01 | Joseph Donald Director | Grant or award · Stock Option (right to buy) | +16,400 | 16,400 | ||
| 2017-08-01 | PARKER H STEWART Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2017-08-01 | MATTINGLY MARTIN A Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2017-08-01 | JACOBS CINDY EVP, CMO | Grant or award · Stock Option (right to buy) | +274,000 | 274,000 |
Page 18 of 36 · 715 trades